406 related articles for article (PubMed ID: 17491584)
1. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
2. Perforating dermatosis in a patient receiving bevacizumab.
Vano-Galvan S; Moreno C; Medina J; Pérez-García B; García-López JL; Jaén P
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):972-4. PubMed ID: 19470057
[No Abstract] [Full Text] [Related]
3. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
Rodriguez NA; Ascaso FJ
J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
[No Abstract] [Full Text] [Related]
4. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
5. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
6. Bevacizumab in the treatment of colorectal cancer.
Marshall JL
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):8-9. PubMed ID: 17491585
[No Abstract] [Full Text] [Related]
7. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
[TBL] [Abstract][Full Text] [Related]
8. [Bevacizumab in the treatment of colorectal carcinoma: news from ASCO 2008].
Mansueto G; Longo F
Tumori; 2008; 94(4):suppl 1-14. PubMed ID: 18822711
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
10. Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer.
Vaidyanathan G; Groman A; Wilding G; Fakih MG
Oncology; 2010; 79(1-2):67-71. PubMed ID: 21071992
[TBL] [Abstract][Full Text] [Related]
11. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the treatment of metastatic colorectal cancer with bevacizumab].
Longo F; Mansueto G
Tumori; 2006; 92(5):suppl 1-12. PubMed ID: 17168449
[No Abstract] [Full Text] [Related]
13. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
Dohn LH; Jensen BV; Larsen FO
Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
[No Abstract] [Full Text] [Related]
14. First description of an uterine perforation potentially imputable to treatment with bevacizumab.
Uguen T; Leconte B; Desgrippes R; Tchoundeu B; Bretagne JF; Manfredi S
Acta Oncol; 2012 Nov; 51(8):1102-4. PubMed ID: 23020310
[No Abstract] [Full Text] [Related]
15. [Progress of chemotherapy in colorectal cancer].
Komatsu Y
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761
[No Abstract] [Full Text] [Related]
16. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
Cassidy J
Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
[No Abstract] [Full Text] [Related]
17. Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
Klinger M; Tamandl D; Eipeldauer S; Hacker S; Herberger B; Kaczirek K; Dorfmeister M; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2010 Aug; 17(8):2059-65. PubMed ID: 20177795
[TBL] [Abstract][Full Text] [Related]
18. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
Mohammed TA; Dennie T; Holen KD
Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
[No Abstract] [Full Text] [Related]
19. The treatment of colorectal carcinoma: standard chemotherapy and beyond.
Eng C; Abbruzzese JL
Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242
[TBL] [Abstract][Full Text] [Related]
20. Improved first-line chemotherapy: a better chance for surgery?
Tejpar S; Van Cutsem E; Adam R
Lancet Oncol; 2010 Jan; 11(1):4-5. PubMed ID: 19942480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
